Article | June 18, 2015

Impact Of Missing ePRO Data On Clinical Trials

JenniferRoss_ElisaHolzbaur

By Jennifer Ross, Lead Biostatistician and Elisa Holzbaur, Manager, ePRO Services, Almac Group

The quality of electronic Patient Reported Outcome (ePRO) data far exceeds that of data collected on paper, as various forms of missing data can be prevented.  However, even with automated reminders, patients may still be non-compliant with ePRO assessments, leading to missing data.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader